scholarly article | Q13442814 |
P356 | DOI | 10.3171/SPI-07/08/151 |
P698 | PubMed publication ID | 17688054 |
P50 | author | Jeffrey Weinberg | Q42636015 |
Charles S Cleeland | Q88086168 | ||
P2093 | author name string | Anita Mahajan | |
Ehud Mendel | |||
Laurence D Rhines | |||
Pamela K Allen | |||
Eric L Chang | |||
Shiao Y Woo | |||
Xin Shelly Wang | |||
Moshe H Maor | |||
Almon S Shiu | |||
Barry W Brown | |||
Leni A Mathews | |||
P433 | issue | 2 | |
P304 | page(s) | 151-160 | |
P577 | publication date | 2007-08-01 | |
P1433 | published in | Journal of Neurosurgery-Spine | Q15752109 |
P1476 | title | Phase I/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure | |
P478 | volume | 7 |
Q41645384 | A call for the aggressive treatment of oligometastatic and oligo-recurrent non-small cell lung cancer |
Q36491373 | A review of recently published radiotherapy treatment guidelines for bone metastases: Contrasts or convergence? |
Q42202755 | A single-dose conformal delivery of radiotherapy following osteoplasty : a novel approach to treatment of osteolytic metastasis in the setting of multiple myeloma |
Q39771088 | A survey of stereotactic body radiotherapy use in the United States |
Q38790915 | A systematic review of outcomes following stereotactic ablative radiotherapy in the treatment of early-stage primary lung cancer |
Q36534796 | Accuracy of marketing claims by providers of stereotactic radiation therapy |
Q47587062 | An integrated multidisciplinary algorithm for the management of spinal metastases: an International Spine Oncology Consortium report. |
Q34985841 | CT-guidance interstitial (125)Iodine seed brachytherapy as a salvage therapy for recurrent spinal primary tumors |
Q39329017 | Clinical applicability of biologically effective dose calculation for spinal cord in fractionated spine stereotactic body radiation therapy |
Q41117173 | Clinical outcome of vertebral compression fracture after single fraction spine radiosurgery for spinal metastases |
Q50225647 | Clinical outcomes of multileaf collimator-based CyberKnife for spine stereotactic body radiation therapy. |
Q36166881 | Clinical outcomes of stereotactic body radiotherapy for spinal metastases from hepatocellular carcinoma |
Q30428253 | Clinical practice of image-guided spine radiosurgery--results from an international research consortium |
Q44946517 | Commissioning and initial stereotactic ablative radiotherapy experience with Vero |
Q36200258 | Comparing conVEntional RadioTherapy with stereotactIC body radiotherapy in patients with spinAL metastases: study protocol for an randomized controlled trial following the cohort multiple randomized controlled trial design |
Q91305199 | Comparison of Clinical Outcomes Stratified by Target Delineation for Patients Undergoing Stereotactic Body Radiotherapy for Spinal Metastases |
Q35121736 | Comparison of outcomes in patients with stage III versus limited stage IV non-small cell lung cancer |
Q30275416 | Consensus Contouring Guidelines for Postoperative Stereotactic Body Radiation Therapy for Metastatic Solid Tumor Malignancies to the Spine |
Q30275436 | Consensus guidelines for postoperative stereotactic body radiation therapy for spinal metastases: results of an international survey. |
Q38421253 | Contemporary treatment with radiosurgery for spine metastasis and spinal cord compression in 2015. |
Q36639798 | Conventionally-fractionated image-guided intensity modulated radiotherapy (IG-IMRT): a safe and effective treatment for cancer spinal metastasis |
Q42557288 | Correlation of local failure with measures of dose insufficiency in the high-dose single-fraction treatment of bony metastases |
Q30467551 | Current concepts in stereotactic radiosurgery - a neurosurgical and radiooncological point of view |
Q90682121 | Decision Making in Patients With Metastatic Spine. The Role of Minimally Invasive Treatment Modalities |
Q35318609 | Deoxynucleoside salvage facilitates DNA repair during ribonucleotide reductase blockade in human cervical cancers |
Q38628837 | Dose Evaluation of Fractionated Schema and Distance From Tumor to Spinal Cord for Spinal SBRT with Simultaneous Integrated Boost: A Preliminary Study. |
Q37876669 | Dose tolerance limits and dose volume histogram evaluation for stereotactic body radiotherapy |
Q52677059 | Dose-intensified hypofractionated stereotactic body radiation therapy for painful spinal metastases: Results of a phase 2 study. |
Q38629152 | Dosimetric analysis of varying cord planning organ at risk volume in spine stereotactic body radiation therapy |
Q50875641 | Dosimetric comparison of Acuros XB with collapsed cone convolution/superposition and anisotropic analytic algorithm for stereotactic ablative radiotherapy of thoracic spinal metastases. |
Q47157174 | Dosimetric evaluation of target coverage as a predictor of local failure following stereotactic body radiation therapy for spinal tumors |
Q47160855 | Dosimetric impact of angular deviations in positioning for spinal radiosurgery |
Q90279869 | Dosimetric study for spine stereotactic body radiation therapy: magnetic resonance guided linear accelerator versus volumetric modulated arc therapy |
Q39098306 | Effective local control of vertebral metastases by simultaneous integrated boost radiotherapy: preliminary results |
Q47326988 | Estimating normal tissue toxicity in radiosurgery of the CNS: application and limitations of QUANTEC. |
Q92134450 | Evaluation of Elements Spine SRS Plan Quality for SRS and SBRT Treatment of Spine Metastases |
Q36243980 | Evaluation of efficacy and safety of robotic stereotactic body radiosurgery and hypofractionated stereotactic radiotherapy for vertebral metastases |
Q35970973 | Fiducial-free CyberKnife stereotactic body radiation therapy (SBRT) for single vertebral body metastases: acceptable local control and normal tissue tolerance with 5 fraction approach |
Q83856551 | Follow-up CT and MR findings of osteoblastic spinal metastatic lesions after stereotactic radiotherapy |
Q34481244 | Fractionated radiosurgery for painful spinal metastases: DOSIS - a phase II trial |
Q36196005 | Helical tomotherapy for spine oligometastases from gastrointestinal malignancies |
Q92864450 | Hypofractionated Image-Guided Radiation Therapy With Simultaneous-Integrated Boost Technique for Limited Metastases: A Multi-Institutional Analysis |
Q30491424 | Impact of collimator leaf width and treatment technique on stereotactic radiosurgery and radiotherapy plans for intra- and extracranial lesions |
Q43120283 | Influence of rotations on dose distributions in spinal stereotactic body radiotherapy (SBRT). |
Q47102842 | Internal validation of the prognostic index for spine metastasis (PRISM) for stratifying survival in patients treated with spinal stereotactic radiosurgery |
Q47143635 | Investigating the dosimetric effects of grid size on dose calculation accuracy using volumetric modulated arc therapy in spine stereotactic radiosurgery |
Q45333139 | Irradiation of Spinal Metastases: Should We Continue to Include One Uninvolved Vertebral Body Above and Below in the Radiation Field? |
Q44251937 | Is helical tomotherapy accurate and safe enough for spine stereotactic body radiotherapy? |
Q64251198 | Local control and vertebral compression fractures following stereotactic body radiotherapy for spine metastases |
Q64997111 | Local failure and vertebral body fracture risk using multifraction stereotactic body radiation therapy for spine metastases. |
Q88425219 | Long-Term Outcomes After Stereotactic Radiosurgery for Spine Metastases: Radiation Dose-Response for Late Toxicity |
Q39204909 | Long-term safety and efficacy of fractionated stereotactic body radiation therapy for spinal metastases |
Q36718847 | Metachronous presentation of metastasis from renal cell carcinoma: evaluation and management of spinal metastasis |
Q39441188 | Modern approaches to the management of metastatic epidural spinal cord compression |
Q60046002 | Multidisciplinary approach for post-liver transplant recurrence of hepatocellular carcinoma: A proposed management algorithm |
Q30484881 | Normal tissue toxicity after small field hypofractionated stereotactic body radiation |
Q88241543 | Oropharyngeal Dysphagia Evaluation Tools in Adults with Solid Malignancies Outside the Head and Neck and Upper GI Tract: A Systematic Review |
Q97541985 | Outcome and toxicity of hypofractionated image-guided SABR for spinal oligometastases |
Q35190502 | Outcomes and toxicities of stereotactic body radiation therapy for non-spine bone oligometastases |
Q30426369 | Pathological vertebral fracture after stereotactic body radiation therapy for lung metastases. Case report and literature review |
Q36793780 | Phase 1/2 trial of single-session stereotactic body radiotherapy for previously unirradiated spinal metastases |
Q41967061 | Positional Accuracy of Treating Multiple Versus Single Vertebral Metastases With Stereotactic Body Radiotherapy |
Q35750652 | Prevention and Treatment of Bone Metastases in Breast Cancer |
Q39185475 | Prognostic factors associated with pain palliation after spine stereotactic body radiation therapy |
Q37841372 | Prospective evaluation of spinal reirradiation by using stereotactic body radiation therapy: The University of Texas MD Anderson Cancer Center experience |
Q47146254 | Prospective validation of treatment accuracy using implanted fiducial markers for spinal stereotactic body radiation therapy |
Q30416741 | Quality and safety considerations in stereotactic radiosurgery and stereotactic body radiation therapy: Executive summary |
Q37011543 | RTOG 0631 phase 2/3 study of image guided stereotactic radiosurgery for localized (1-3) spine metastases: phase 2 results |
Q38685466 | Radiobiology of stereotactic body radiation therapy (SBRT). |
Q36582921 | Radiosurgery Compared with External Radiation Therapy as a Primary Treatment in Spine Metastasis from Hepatocellular Carcinoma : A Multicenter, Matched-Pair Study |
Q37534318 | Radiosurgery for spinal malignant tumors |
Q43897534 | Radiosurgery using the Cyberknife for benign spinal tumors: Korea Cancer Center Hospital experience |
Q26864247 | Review and uses of stereotactic body radiation therapy for oligometastases |
Q39251763 | Review of stereotactic radiosurgery for intradural spine tumors |
Q47133015 | Risk of vertebral compression fracture specific to osteolytic renal cell carcinoma spinal metastases after stereotactic body radiotherapy: A multi-institutional study |
Q38872884 | Robotic Radiosurgery for the Treatment of Intramedullary Spinal Cord Metastases: A Case Report and Literature Review |
Q52624075 | Role of radiotherapy in extracranial metastatic malignant melanoma in the modern era. |
Q38233126 | Role of stereotactic body radiotherapy in spinal metastasis and subsequent fracture risk: identifying and treating the at-risk patient |
Q52945416 | Single fraction spine stereotactic ablative body radiotherapy with volumetric modulated arc therapy. |
Q91738235 | Single-Fraction Radiotherapy (SFRT) For Bone Metastases: Patient Selection And Perspectives |
Q34781650 | Spinal cord tolerance in the age of spinal radiosurgery: lessons from preclinical studies |
Q38677022 | Spinal metastases: From conventional fractionated radiotherapy to single-dose SBRT. |
Q35690484 | Spinal radiosurgery--efficacy and safety after prior conventional radiotherapy |
Q47121395 | Spinal radiosurgery: a neurosurgical perspective |
Q37278149 | Spinal radiosurgery: technology and clinical outcomes. |
Q39308768 | Spine Stereotactic Body Radiotherapy: Indications, Outcomes, and Points of Caution |
Q83862664 | Spine instrumentation failure after spine tumor resection and radiation: comparing conventional radiotherapy with stereotactic radiosurgery outcomes |
Q47134226 | Spine radiosurgery for spinal cord compression: the radiation oncologist's perspective |
Q28079505 | Spine radiosurgery for the local treatment of spine metastases: Intensity-modulated radiotherapy, image guidance, clinical aspects and future directions |
Q57826816 | Stereotactic Body Radiation Therapy for Spinal Malignancies |
Q64074521 | Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Spine Metastases: An Overview |
Q38917489 | Stereotactic Body Radiotherapy for Spinal Metastases: What are the Risks and How Do We Minimize Them? |
Q47140283 | Stereotactic ablative body radiotherapy (SABR) for effective palliation of metastases: factors affecting local control |
Q42700730 | Stereotactic ablative body radiotherapy for spinal metastasis from hepatocellular carcinoma: its oncologic outcomes and risk of vertebral compression fracture |
Q57177641 | Stereotactic body radiation therapy for lung, spine and oligometastatic disease: current evidence and future directions |
Q28709611 | Stereotactic body radiation therapy for management of spinal metastases in patients without spinal cord compression: a phase 1-2 trial |
Q37790167 | Stereotactic body radiation therapy for spinal metastases |
Q37649474 | Stereotactic body radiation therapy: a novel treatment modality |
Q35687568 | Stereotactic body radiosurgery for spinal metastatic disease: an evidence-based review |
Q36915978 | Stereotactic body radiotherapy for lesions of the spine and paraspinal regions |
Q41340312 | Stereotactic body radiotherapy for metastatic spinal sarcoma: a detailed patterns-of-failure study. |
Q45170619 | Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease |
Q39044493 | Stereotactic body radiotherapy for recurrent head and neck cancer: A critical review |
Q41910000 | Stereotactic body radiotherapy for solitary spine metastasis |
Q38046079 | Stereotactic body radiotherapy treatment of extracranial metastases |
Q39207551 | Stereotactic radiosurgery compared with external radiation therapy as a primary treatment in spine metastasis from renal cell carcinoma: a multicenter, matched-pair study |
Q34811295 | Stereotactic radiosurgery for spinal metastases: a literature review |
Q37544922 | Stereotactic radiosurgery in the management of cancer pain |
Q46022001 | Submillimeter alignment of more than three contiguous vertebrae in spinal SRS/SBRT with 6-degree couch. |
Q36396372 | Survival-Related Factors of Spinal Metastasis with Hepatocellular Carcinoma in Current Surgical Treatment Modalities : A Single Institute Experience |
Q37409902 | The Effect of Perioperative Radiation Therapy on Spinal Bone Fusion Following Spine Tumor Surgery |
Q41450381 | The Metastatic Spine Disease Multidisciplinary Working Group Algorithms. |
Q38109622 | The NOMS framework: approach to the treatment of spinal metastatic tumors |
Q55223014 | The SBRT database initiative of the German Society for Radiation Oncology (DEGRO): patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver oligometastases in 474 patients with 623 metastases. |
Q38009256 | The role of radiation therapy in controlling painful bone metastases |
Q26823733 | The role of radiation therapy in the treatment of metastatic castrate-resistant prostate cancer |
Q35794711 | The role of stereotactic radiosurgery in metastasis to the spine. |
Q38233173 | Update on management of vertebral column tumors. |
Q40427837 | Value of postoperative stereotaxic body radiation therapy for spinal metastases |
Q37097528 | Variation in Practice Patterns of Korean Radiation Oncologists for Spine Metastasis between 2009 and 2014 |
Q36228265 | What Is the Value of Surgical Intervention for Sacral Metastases? |
Q38983894 | When Less Is More: The indications for MIS Techniques and Separation Surgery in Metastatic Spine Disease. |
Search more.